Clinical Trials Sponsored by Gruppo di Ricerca GISSI

Total 28 results

Gruppo di Ricerca GISSI

Completed

GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

Atrial Fibrillation

Italy, Switzerland
Gruppo di Ricerca GISSI

Completed

Investigation of Patients With BAV Requiring Valve and/or Aortic Repair (GISSI Outliers VAR) (VAR)

Aortic Regurgitation | Bicuspid Aortic Valve | Aortic Dilatation

Italy
Gruppo di Ricerca GISSI

Completed

GISSI Outliers CAPIRE (CAPIRE)

Atherosclerosis

Italy, Switzerland
Gruppo di Ricerca GISSI

Completed

GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF

Heart Failure

Italy, Switzerland
Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting

Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer (C-MSI)

Colorectal Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma (NIVES)

Renal Cancer Metastatic

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Unknown

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients (NIVACOR)

Colorectal Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting

Alectinib in Neo-adjuvant Treatment of Stage III NSCLC (ALNEO)

Non Small Cell Lung Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) (AtezoMeso)

Mesotheliomas Pleural

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy (EDOI)

Cancer | Thromboembolism

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.

Carcinoma, Renal Cell

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Unknown

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC

Advanced Non-Small Cell Lung Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting

Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer (a-MANTRA)

Gastric Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Unknown

A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM (RAMES)

Mesothelioma

Italy
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer (NabucCO)

Metastatic Pancreatic Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
Novartis

Active, not recruiting

Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin

Neuroendocrine Carcinoma

Italy
Istituti Tumori Giovanni Paolo II
Gruppo Oncologico Italiano di Ricerca Clinica; Gruppo Oncologico Italia Meridionale and other collaborators

Unknown

Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer (GIP-1)

Pancreatic Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
Istituto Toscano Tumori; Temas srl; Clirest s.r.l.; Mipharm S.p.A.

Unknown

Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLC (Nabster)

Small Cell Lung Cancer

Italy
Ciceri Fabio
Associazione Italiana per la Ricerca sul Cancro; Gruppo Italiano Trapianto...

Recruiting

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways (GITMO-RELAPSE)

Acute Myeloid Leukemia, in Relapse

Italy
National Cancer Institute, Naples
Gruppo Oncologico Italia Meridionale; Gruppo Italiano per lo studio dei Carcinomi... and other collaborators

Terminated

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients (CAPPA-2)

Non-Small Cell Lung Cancer

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
Bioikos Ambiente Srl; Istituto Toscano Tumori; Temas srl; Mipharm S.p.A.; Bristol...

Active, not recruiting

Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial) (EDEN)

Squamous Non-small Cell Lung Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Istituto Di Ricerche Farmacologiche Mario Negri; Gruppo Oncologico del Nord-Ovest

Recruiting

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation (COLT)

Neoplasms | Colorectal Cancer Metastatic | Liver Metastases | Liver Neoplasm

Italy
Mario Negri Institute for Pharmacological Research
Aventis Pharmaceuticals; Istituto Scientifico Romagnolo per lo Studio e la... and other collaborators

Completed

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S)

Adenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the Stomach

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
YGHEA, CRO Division of Ecol Studio spa; Roche Pharma, Italy; Dr. Luca Boni U.O...

Active, not recruiting

Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer (CeLEBrATE)

Small Cell Lung Cancer

Italy
European Organisation for Research and Treatment...
Federation Francophone de Cancerologie Digestive; Arbeitsgemeinschaft fur Internistische... and other collaborators

Completed

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Colorectal Cancer

Netherlands, Belgium, Austria
European Organisation for Research and Treatment...
Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaborators

Active, not recruiting

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

Breast Cancer Stage II | Breast Cancer Stage III

Spain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
Gruppo Oncologico Italiano di Ricerca Clinica
Mipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department... and other collaborators

Unknown

Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients (IMMUN-HER)

Cancer, Breast

Italy
Gruppo Oncologico Italiano di Ricerca Clinica
Iqvia Pty Ltd; AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations... and other collaborators

Completed

Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) (CHANCE)

Non-Small Cell Lung Cancer

Italy

Clinical Trials Sponsored by Gruppo di Ricerca GISSI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations